SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-092073
Filing Date
2017-03-22
Accepted
2017-03-22 16:06:03
Documents
15
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d364020d20f.htm 20-F 1756945
2 EX-8.1 d364020dex81.htm EX-8.1 2825
3 EX-12.1 d364020dex121.htm EX-12.1 6562
4 EX-12.2 d364020dex122.htm EX-12.2 6522
5 EX-13.1 d364020dex131.htm EX-13.1 4122
6 GRAPHIC g364020g0321115900325.jpg GRAPHIC 36976
7 GRAPHIC g364020g0321115900450.jpg GRAPHIC 61156
8 GRAPHIC g364020g0321115900590.jpg GRAPHIC 57273
9 GRAPHIC g364020g0321115900699.jpg GRAPHIC 44460
10 GRAPHIC g364020g0321115900809.jpg GRAPHIC 42405
11 GRAPHIC g364020g11a18.jpg GRAPHIC 2055
12 GRAPHIC g364020g22e91.jpg GRAPHIC 84378
13 GRAPHIC g364020g56y71.jpg GRAPHIC 1617
14 GRAPHIC g364020g70s19.jpg GRAPHIC 1668
15 GRAPHIC g364020g81x69.jpg GRAPHIC 16430
  Complete submission text file 0001193125-17-092073.txt   2258244
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36815 | Film No.: 17706752
SIC: 2834 Pharmaceutical Preparations